PHASEBIO PHARMACEUTICALS INC (PHAS)
US7172241090 - Common Stock
| TTM (2022-6-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -102.84M | -131.07M | -98.57M | -39.25M | -23.85M | |||
| Depreciation Amortization | 1.94M | 1.79M | 510.00K | 170.00K | 110.00K | |||
| Change In Working Capital | 28.63M | 29.37M | -4.26M | -2.44M | 2.03M | |||
| Interest Paid | 338.00K | 517.00K | 950.00K | 580.00K | 260.00K | |||
| Other non cash items | 12.85M | 52.49M | 42.36M | 1.92M | 4.66M | |||
| OPERATING CASH FLOW | -59.42M | -47.42M | -59.96M | -39.59M | -17.05M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.40M | -2.68M | -1.41M | -960.00K | -120.00K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | -2.40M | -2.68M | -1.41M | -960.00K | -120.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -5.46M | -5.46M | -2.73M | 7.15M | 4.00M | |||
| Stock Issued/Repurchased | 2.44M | 61.08M | 3.22M | 46.52M | 60.80M | |||
| Other Financing Activity | N/A | 8.14M | 14.97M | -150.00K | N/A | |||
| FINANCING CASH FLOW | 5.17M | 63.77M | 15.47M | 53.53M | 64.80M | |||
| CHANGE IN CASH | -56.65M | 13.68M | -45.90M | 12.98M | 47.63M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -59.42M | -47.42M | -59.96M | -39.59M | -17.05M | |||
| Capital Expenditure | -2.40M | -2.68M | -1.41M | -960.00K | -120.00K | |||
| FREE CASH FLOW | -61.82M | -50.09M | -61.37M | -40.55M | -17.17M | |||
All data in USD